4.5 Article

Cerebral sinus venous thrombosis in Swiss children

Journal

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
Volume 52, Issue 12, Pages 1145-1150

Publisher

WILEY
DOI: 10.1111/j.1469-8749.2010.03722.x

Keywords

-

Funding

  1. Swiss Heart Foundation
  2. Swiss Foundation for Neuropsychological Science
  3. Novartis Research Foundation

Ask authors/readers for more resources

AIM To describe the characteristics of paediatric cerebral sinus venous thrombosis (CSVT) in Switzerland. METHOD Data on clinical features, neuroimaging, risk factors, and treatment were collected for all children in Switzerland younger than 16 years of age who had CSVT between January 2000 and December 2008. A follow-up examination and a cognitive assessment were performed (mean follow-up period 26mo). Differences between neonates and children (patients older than 28d) were assessed and predictors of outcome were determined. RESULTS Twenty-one neonates (14males, seven females; mean age 9d, SD 8d) and 44 children (30 males, 14 females; mean age 8y 7mo, SD 4y 5mo) were reported. The incidence of paediatric CSVT in Switzerland was 0.558 per 100 000 per year. In neonates, the deep venous system was more often involved and parenchymal injuries were more common. The strongest predictor of poor outcome was neonatal age (odds ratio 17.8, 95% confidence interval 0.847-372.353). Most children showed global cognitive abilities within the normal range, but impairments in single cognitive subdomains were frequent. INTERPRETATION Paediatric CSVT is rare. Its outcome is poor in neonates. Most children have good neurological outcomes, but some patients have individual neuropsychological impairments.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available